Naltrexone and Adrenergic Agents to Reduce Heroin Use in Heroin Addicts

NCT00142948 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

301

Enrollment

OTHER

Sponsor class

Conditions

Heroin Dependence

Interventions

DRUG: Naltrexone
DRUG: Placebo

Sponsor

Baylor College of Medicine

Collaborators

[object Object]